Finance

Lists
Why is SRTA down 2,07%?
Dive Deeper
SRTA:NASDAQ
Strata Critical Medical Inc
4,73 US$
-2,07%
(-0,100) 1D
4,73 US$
0,00% (0,00)
After hours
Closed: 2 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SRTA...
Open
4,90 US$
High
4,92 US$
Low
4,71 US$
Mkt. cap
418,45 მლნ.
Avg. vol.
832,85 ათ.
Volume
999,67 ათ.
P/E ratio
9,58
52-wk high
6,50 US$
52-wk low
3,95 US$
EPS
0,49 US$
Beta
2,43
Shares outstanding
88,47 მლნ.
No. of employees
327
Open
4,90 US$
High
4,92 US$
Low
4,71 US$
Mkt. cap
418,45 მლნ.
Avg. vol.
832,85 ათ.
Volume
999,67 ათ.
P/E ratio
9,58
52-wk high
6,50 US$
52-wk low
3,95 US$
EPS
0,49 US$
Beta
2,43
Shares outstanding
88,47 მლნ.
No. of employees
327
News stories
From web sources and news partners
About Strata Critical Medical Inc
CEO-
Employees327
Founded2014
Headquarters-
SectorHealth care provider
Websitestratacritical.com
Analyst ratings
Based on 1 analyst giving stock ratings to SRTA in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for SRTA in the last 3 months
Highest
Current 4,73 US$
9,50 US$ (+100,85%)
Average
9,50 US$ (+100,85%)
Lowest
9,50 US$ (+100,85%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ben Haynor
Lake Street
Buy
Reiterated
9,50 US$
+100,8%
08/05/2026
William Bonello
Craig-Hallum
Buy
Maintained
-
-
06/26/2026
Jon Hickman
Ladenburg Thalmann & Co.
Buy
Reiterated
11,50 US$
+143,1%
05/07/2026
Yuan Zhi
B. Riley Securities
Buy
Initiated
8,00 US$
+69,1%
03/25/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
49,30 მლნ.
66,79 მლნ.
67,38 მლნ.
72,51 მლნ.
Cost of goods sold
37,68 მლნ.
55,12 მლნ.
53,27 მლნ.
57,29 მლნ.
Cost of revenue
37,68 მლნ.
55,12 მლნ.
53,27 მლნ.
57,29 მლნ.
Research and development expenses
453,00 ათ.
-1,35 მლნ.
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,74 მლნ.
13,99 მლნ.
14,54 მლნ.
13,17 მლნ.
Operating expense
12,19 მლნ.
15,24 მლნ.
16,02 მლნ.
19,80 მლნ.
Total operating expenses
49,88 მლნ.
70,35 მლნ.
69,29 მლნ.
77,09 მლნ.
Operating income
-577,00 ათ.
-3,57 მლნ.
-1,90 მლნ.
-4,58 მლნ.
Other non operating income
33,00 ათ.
1,42 მლნ.
1,46 მლნ.
71,00 ათ.
EBT including unusual items
-9,66 მლნ.
-5,39 მლნ.
2,40 მლნ.
-10,52 მლნ.
EBT excluding unusual items
583,00 ათ.
-1,51 მლნ.
27,00 ათ.
-4,18 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
57,42 მლნ.
-8,83 მლნ.
2,15 მლნ.
-10,52 მლნ.
Net profit margin
116,47%
-13,23%
3,20%
-14,50%
Earnings per share
-
-
0,04
-
Interest and investment income
1,13 მლნ.
638,00 ათ.
473,00 ათ.
331,00 ათ.
Interest expense
-
-
-
-
Net interest expenses
1,13 მლნ.
638,00 ათ.
473,00 ათ.
331,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-158,00 ათ.
-558,00 ათ.
1,16 მლნ.
3,93 მლნ.
Gain or loss from assets sale
-60,44 მლნ.
-
344,00 ათ.
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები